Treatment of Disseminated Classic Type of Kaposi's Sarcoma with Paclitaxel.
- Author:
Soo Yeon KIM
1
;
Dae Hoon KIM
;
Hyo Jin LEE
;
Young Joon SEO
;
Jeung Hoon LEE
;
Young LEE
Author Information
- Publication Type:Case Report
- Keywords: Kaposi sarcoma; Paclitaxel
- MeSH: Humans; Korea; Male; Paclitaxel; Sarcoma, Kaposi; Viruses
- From:Annals of Dermatology 2011;23(4):504-507
- CountryRepublic of Korea
- Language:English
- Abstract: Classic Kaposi sarcoma (KS) is a rare human herpes virus 8-associated angioproliferative disease, and the disseminated classic type of KS in Korea is even rarer. The treatment options for classic KS vary and range from surgical excision to ionizing irradiation or chemotherapy. Recently, there have been a few reports of treating classic KS with paclitaxel, which has been used to treat AIDS-associated KS and post-transplant KS. We herein report a case of disseminated classic type KS in a 78-year-old Korean male patient who showed dramatic response after only two cycles of paclitaxel treatment.
